Live feed
Filing
SC 13D
SC 13D0001193125-19-186324·Akero Therapeutics, Inc.
Schedule 13D ownership disclosure
AKERO THERAPEUTICS INC
Security class unavailable · CUSIP: 00973Y108
Event date: 2019-06-24
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 19.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-19-186324
- Form type
- SC 13D
- Filer
- Akero Therapeutics, Inc.
- CIK
- CIK 1744659
- Filed
- Jul 01, 2019
- Reporting period
- Jun 24, 2019
- Description
- Schedule 13D beneficial ownership